Experiments for taxon Agelas dispar (AGELASIDAE)

Experiments (52 results)

Filters
Worktypes (13)
23
20
17
12
9
8
7
6
5
3
1
1
1
No match
Pharmacology (8)
6
5
5
1
1
1
1
32
No match
Compounds (40)
4
4
4
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (8)
13
11
10
6
4
4
3
1
No match
52 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
238759
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Agelas dispar (AGELASIDAE)
BETAINE B,PYRIDINE:
1316854
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Agelas dispar (AGELASIDAE)
DIBROMOAGELASPONGIN METHYL ETHER
238760
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
ZOOANEMONIN
216224
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RECEPTOR BINDING ACTIVITY
Agelas dispar (AGELASIDAE)
DISPACAMIDE C
340358
PARTIAL STRUCTURE ELUCIDATION OFPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREWRITE LETTER FOR 1 COMPOUND
Agelas dispar (AGELASIDAE)
AGELASINE
238755
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Agelas dispar (AGELASIDAE)
BETAINE A,PYRIDINE:
188180
PHARMACOLOGY OF COMPOUND - IN VITRO
SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT
Agelas dispar (AGELASIDAE)
DISPACAMIDE
216219
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
DISPACAMIDE A
1195792
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Agelas dispar (AGELASIDAE)
CHOLEST-8(9)-EN-3-BETA-OL,5-ALPHA: 4-ALPHA-METHYL-24-ETHYL:
216213
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
SCEPTRIN
1316855
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
PHAKELLIN,DIBROMO:
200038
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE PROLIFERATION STIMULATION
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 1-A
216217
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RECEPTOR BINDING ACTIVITY
Agelas dispar (AGELASIDAE)
OROIDIN
238761
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELASIDINE C
238756
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Agelas dispar (AGELASIDAE)
BETAINE A,PYRIDINE:
216223
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
DISPACAMIDE D
200036
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 1-A
238758
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Agelas dispar (AGELASIDAE)
BETAINE A,PYRIDINE:
1195795
PMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
CHOLESTA-7-22-DIEN-3-BETA-OL,5-ALPHA: 24-METHYL:
188179
PHARMACOLOGY OF COMPOUND - IN VITRO
ACH RECEPTOR BLOCKING EFFECT
Agelas dispar (AGELASIDAE)
DISPACAMIDE
188181
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Agelas dispar (AGELASIDAE)
DISPACAMIDE
211536
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AJUGASTERONE CECDYSONE,BETA:
238752
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Agelas dispar (AGELASIDAE)
ZOOANEMONIN,AMINO:
216220
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
DISPACAMIDE B
200033
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE PROLIFERATION STIMULATION
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 3
216216
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELONGINE
238751
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Agelas dispar (AGELASIDAE)
ZOOANEMONIN,AMINO:
200032
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 4
238753
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Agelas dispar (AGELASIDAE)
ZOOANEMONIN,AMINO:
1316853
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Agelas dispar (AGELASIDAE)
DISPYRIN
211535
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
KERAMADINE
216222
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
DISPACAMIDE C
216215
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
OROIDIN
238757
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Agelas dispar (AGELASIDAE)
BETAINE A,PYRIDINE:
1316856
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
PHAKELLIN,MONOBROMO:
200035
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 5
200029
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 2
1195794
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
CHOLESTA-5-7-22-TRIEN-3-BETA-OL,24-ETHYL:
216221
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE ANTAGONIST ACTIVITY
Agelas dispar (AGELASIDAE)
DISPACAMIDE ADISPACAMIDE B
211534
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Agelas dispar (AGELASIDAE)
CLATHRAMIDE DLONGAMIDE BCLATHRAMIDE C
238754
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBACTERIAL ACTIVITY
Agelas dispar (AGELASIDAE)
ZOOANEMONIN,AMINO:
200031
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 3
188178
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
DISPACAMIDE
200034
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE PROLIFERATION STIMULATION
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 4
1316857
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
PHAKELLIN,ISO: DIBROMO:
216214
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RECEPTOR BINDING ACTIVITY
Agelas dispar (AGELASIDAE)
SCEPTRIN
200037
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE PROLIFERATION STIMULATION
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 5
200030
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE PROLIFERATION STIMULATION
Agelas dispar (AGELASIDAE)
AGELAS GLYCOSYL CERAMIDE 2
1195793
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
CHOLESTAN-3-BETA-OL,5-ALPHA: 24-ETHYL:CHOLESTAN-3-BETA-OL,5-ALPHA:CHOLEST-8(9)-EN-3-BETA-OL,5-ALPHA: 4-ALPHA-METHYL:CHOLEST-7-EN-3-BETA-OL,5-ALPHA: 24-ETHYL:CHOLEST-8(9)-EN-3-BETA-OL,5-BETA: 4-ALPHA-METHYL:CHOLESTA-7-TRANS-22-DIEN-3-BETA-OL,24-ETHYL:
1316858
ISOLATION AND IDENTIFICATION OF
Agelas dispar (AGELASIDAE)
AGELASPONGIN,DIBROMO:
216218
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RECEPTOR BINDING ACTIVITY
Agelas dispar (AGELASIDAE)
AGELONGINE
216225
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RECEPTOR BINDING ACTIVITY
Agelas dispar (AGELASIDAE)
DISPACAMIDE D